RB activation defect in tumor cell lines.
Activation of the retinoblastoma (RB) protein through dephosphorylation arises in cells upon exit from M phase and in response to environmental stresses, including DNA damage. We provide here for the first time evidence that these responses are co-ordinately affected in a subset of tumor derived cell lines. We find that RB dephosphorylation is not apparent in these cells during progression into G(1). Importantly these cells also do not respond with RB activation after DNA damage during S phase. Moreover and as a consequence they display phenotypes classically associated with RB(-) cells, showing accelerated apoptosis after DNA damage and DNA re-replication after spindle-checkpoint activation. A large body of literature provides evidence that controls governing inactivation of RB are lost in tumors. The results presented here indicate that the reverse reaction, namely the activation of RB from an inactive precursor, may also be compromised. Our findings indicate that this type of defect may be coupled with hypersensitivity to DNA damage and an increase in genomic instability in response to spindle-checkpoint activation thus bearing potentially important medical implications.
Broceño
Cristina
C
Centre for Molecular and Cell Biology, Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London SW3 6JB, United Kingdom.
Wilkie
Scott
S
Mittnacht
Sibylle
S
D004249:DNA Damage; D004261:DNA Replication; D016193:G1 Phase; D006801:Humans; D012516:Osteosarcoma; D010766:Phosphorylation; D016160:Retinoblastoma Protein / Q000378:metabolism*; D008941:Spindle Apparatus; D014407:Tumor Cells, Cultured
D016160:Retinoblastoma Protein